Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
SCANPHARM A/S
A/S
Active
CVR 16279099
Topstykket 12, 3460
Birkerød
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 1992 · 33 years old
42 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
SCANPHARM A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
9M
17M
26M
35M
11M
2021
17M
2022
23M
2023
27M
2024
30M
2025
EBITDA
DKK millions
4M
0M
-3M
-7M
-10M
-8M
2021
-3M
+63%
2022
-2M
+33%
2023
3M
+250%
2024
3M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
11.259
17.399
22.519
26.904
29.717
Staff expenses
-18.906
-21.128
-24.335
-23.962
-24.520
EBITDA
-7.981
-3.394
-1.815
2.942
3.472
Depreciation & amort.
-1.737
-1.811
-1.717
-1.263
-1.751
EBIT
-9.718
-5.205
-3.533
1.679
1.721
Net financials
-1.066
-1.408
-986
-1.135
-759
Profit before tax
-10.785
-6.106
-4.425
583
963
Tax
86
-151
-0
-0
-0
Net profit
-10.871
-5.954
-4.425
583
963
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
28.911
29.659
31.602
35.068
39.207
Equity
1.500
1.500
1.500
2.083
3.045
Long-term debt
3.946
2.907
3.625
3.138
3.196
Short-term debt
23.465
25.252
26.476
29.847
32.966
Total debt
27.411
28.159
30.102
32.986
36.162
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
11.7%
This company
2021
2025
Soliditetsgrad
7.8%
This company
38.2%
Market median
-80% vs market
2021
2025
Egenkapitalforrentning
31.6%
This company
18.4%
Market median
+72% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
3.2%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
0.76×
This company
2021
2025
Gæld/egenkapital
11.87×
This company
0.62×
Market median
-1815% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on SCANPHARM A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
